Low-grade intraepithelial cervical lesions in pregnant women with HPV and vaginal biocenotic disorders

Bebneva T.N., Dikke G.B.

1 Peoples’ Friendship University of Russia, Moscow, Russia; 2 F.I. Inozemtsev Academy of Medical Education, Saint Petersburg, Russia
The authors have established a relationship between intraepithelial cervical lesions and vaginal biocenotic disorders in pregnant women with human papillomavirus (HPV) infection and determined their management tactics. The HPV–positive pregnant women have a high incidence of vaginal dysbiosis (38.7%) that is, in most of them, characterized by co–infection (65%), mainly by anaerobic and aerobic infections (44.1%). High-rate HPV in the pregnant women is associated with bacterial vaginosis, mixed dysbiosis, and their recurrences and with the frequency of atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesions (LSIL) in the presence of an inflammatory response. Restoring the normal microflora contributes to the disappearance of the inflammatory response and to the reduction of ASCUS. Therapy for dysbiosis does not change the rate of LSIL at 3-month follow-up.


human papilloma virus
low-risk squamous intraepithelial cervical lesions
bacterial vaginosis
aerobic vaginitis
vulvovaginal candidiasis


1. Hong Y., Li S.Q., Hu Y.L., Wang Z.Q. Survey of human papillomavirus types and their vertical transmission in pregnant women. BMC Infect. Dis. 2013; 13: 109. doi: 10.1186/1471-2334-13-109.

2. Liu P., Xu L., Sun Y., Wang Z. The prevalence and risk of human papillomavirus infection in pregnant women. Epidemiol. Infect. 2014; 142(8): 1567–78. doi: 10.1017/S0950268814000636.

3. Salcedo M.M., Damin A.P., Agnes G., Pessini S.A., Beitune P.E., Alexandre C.O. et al. Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil. Arch. Gynecol. Obstet. 2015; 292(6): 1273-8. doi: 10.1007/s00404-015-3752-8.

4. Domža G., Gudlevičienė Z., Didžiapetrienė J., Valuckas K.P., Kazbarienė B., Drąsutienė G. Human papillomavirus infection in pregnant women. Arch. Gynecol. Obstet. 2011; 284(5): 1105-12. doi: 10.1007/s00404-010-1787-4.

5. Бебнева Т.Н., Дикке Г.Б. Рецидивирующие нарушения биоценоза влагалища, ассоциированные с бактериальным вагинозом, у беременных женщин с ВПЧ-инфекцией. Акушерство и гинекология. 2018; 9: 52-8. [Bebneva TN, Dikke G.B. Recurrent vaginal disbiosis associated with bacterial vaginosis in pregnant women with HPV infection. Obstetrics and gynecology / Akusherstvo i ginekologiya. 2018; 9: 52-58. (in Russian)].

6. Cubo-Abert M., Centeno-Mediavilla C., Franco-Zabala P., Merced-Vázquez C., Castellví J., García A. et al. Risk factors for progression or persistence of squamous intraepithelial lesions diagnosed during pregnancy. J. Low. Genit. Tract Dis. 2012; 16(1): 34-8. doi: 10.1097/LGT.0b013e31822e83cf.

7. Бебнева Т.Н. Цитологические и кольпоскопические особенности шейки матки у беременных с персистирующей папилломавирусной инфекцией. Доктор.Ру. 2015; Приложение 2: 10-3. [Bebneva T.N. Cytological and colposcopic features of the cervix in pregnant women with persistent papillomavirus infection. Doktor.ru. Gynecology and Endocrinology / Doktor.ru. Ginekologiya i endokrinologiya. 2015; 2(12): 10-13. (in Russian)].

8. Xavier-Júnior J.C., Dufloth R.M., do Vale D.B., Tavares T.A., Zeferino L.C. High-grade squamous intraepithelial lesions in pregnant and non-pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014; 175: 103-6. doi: 10.1016/j.ejogrb.2014.01.018.

9. Origoni M., Salvatore S., Perino A., Cucinella G., Candiani M. Cervical Intraepithelial Neoplasia (CIN) in pregnancy: the state of the art. Eur. Rev. Med. Pharmacol. Sci. 2014; 18(6): 851-60.

10. Mitra A., Mac Intyre D.A., Lee Y.S., Smith A., Marchesi J.R., Lehne B. et al. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci. Rep. 2015; 5: 16865. doi: 10.1038/srep16865. Available at: https://www.nature.com/articles/srep16865

11. Kero K., Rautava J., Syrjänen K., Grenman S., Syrjänen S. Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection. Eur. J. Clin. Microbiol. Infect. Dis. 2017; 36(11): 2215-19. doi: 10.1007/s10096-017-3048-y.

12. Mitra A., MacIntyre D., Lee Y., Smith A., Marchesi J., Lehne B. et al. Characterisation of the vaginal microbiome in cervical intraepithelial neoplasia. Lancet. 2016; 387(Special Issue): S75. doi: 10.1016/S0140-6736(16)00462-1.

13. Gillet E., Meys J.F., Verstraelen H., Bosire C., De Sutter P., Temmerman M., Broeck D.V. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect. Dis. 2011; 11: 10. doi: 10.1186/1471-2334-11-10.

14. Zodzika J., Jermakowa I., Rezeberga D., Vasina O., Vedmedovska N., Donders G.G. Factors related to elelvated vaginal pH in the first trimester of pregnancy. Acta Obstet. Gynecol. Scand. 2011; 90: 41-6. doi: 10.1111/j.1600-0412.2010.01011.x.

15. Donders G., Bellen G., Rezeberga D. Aerobic vaginitis in pregnancy. BJOG. 2011; 118(10): 1163-70. doi: 10.1111/j.1471-0528.2011.03020.x.

16. Sangeetha K.T., Saroj Golia, Vasudha C.L. A study of aerobic bacterial pathogens associated with vaginitis in reproductive age group women (15–45 years) and their sensitivity pattern. Int. J. Res. Med. Sci. 2015; 3(9): 2268-73. doi: 10.18203/2320-6012.ijrms20150615.

17. Rathod S.D., Klausner J.D., Krupp K., Reingold A.L., Madhivanan P. Epidemiologic features of vulvovaginal candidiasis among reproductive-age women in India. Infect. Dis. Obstet. Gynecol. 2012; 2012: ID 859071. doi: 10.1155/2012/859071.

18. Kalantari N., Ghaffari S., Bayani M. Trichomonas, Candida and Gardnerella in cervical smears of Iranian women for cancer screening. N. Am. J. Med. Sci. 2014; 6(1): 25–9. doi: 10.4103/1947-2714.125861.

19. Kone E.S., Balili A.D., Paparisto P.D., Ceka X.R., Petrela E.D. Vaginal infections of Albanian women infected with HPV and their impact in intraepithelial cervical lesions evidenced by Pap test. J. Cytol. 2017; 34(1): 16-21. doi: 10.4103/0970-9371.197592.

20. Lu H., Jiang P.C., Zhang X.D., Hou W.J., Wei Z.H., Lu J.Q. et al. Characteristics of bacterial vaginosis infection in cervical lesions with high risk human papillomavirus infection. Int. J. Clin. Exp. Med. 2015; 8(11):21080-8.

21. Ghosh I., Mandal R., Kundu P., Biswas J. Association of genital infections other than human papillomavirus with pre-invasive and invasive cervical neoplasia. J. Clin. Diagn. Res. 2016; 10(2): XE01-6. doi: 10.7860/JCDR/2016/15305.7173.

22. Tao L., Han L., Li X., Gao Q., Pan L., Wu L. et al. Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing. BMC Public Health. 2014; 14: 1185. doi: 10.1186/1471-2458-14-1185.

23. Kiseki H., Tsukahara Y., Tajima N., Tanaka A., Horimoto A., Hashimura N. Influence of co-infection complicated with human papillomavirus on cervical intraepithelial neoplasia development in patients with atypical squamous cells of undetermined significance. J. Infect. Chemother. 2017; 23(12): 814-9. doi: 10.1016/j.jiac.2017.08.008.

24. Rodriguez-Cerdeira C., Sanchez-Blanco E., Alba A. Evaluation of association between vaginal infections and high-risk human papillomavirus types in female sex workers in Spain. ISRN Obstet. Gynecol. 2012; 2012: 240190. doi: 10.5402/2012/240190.

25. Ramirez-Garcia A., Rementeria A., Aguirre-Urizar J.M., Moragues M.D., Antoran A., Pellon A. et al. Candida albicans and cancer: Can this yeast induce cancer development or progression? Crit. Rev. Microbiol. 2016; 42(2): 181-93. doi: 10.3109/1040841X.2014.913004.

26. Di Paola M., Sani C., Clemente A.M., Iossa A., Perissi E., Castronovo G. et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk human papillomavirus infection. Sci. Rep. 2017; 7(1): 10200. doi: 10.1038/s41598-017-09842-6.

27. Guo Y.L., You K., Qiao J., Zhao Y.M., Geng L. Bacterial vaginosis is conducive to the persistence of HPV infection. Int. J. STD AIDS. 2012; 23(8): 581-4. doi: 10.1258/ijsa.2012.011342.

28. Mongelos P., Mendoza L.P., Rodriguez-Riveros I., Castro A., Gimenez G., Araujo P. et al. Distribution of human papillomavirus (HPV) genotypes and bacterial vaginosis presence in cervical samples from Paraguayan indigenous. Int. J. Infect. Dis. 2015; 39: 44-9. doi: 10.1016/j.ijid.2015.08.007.

29. Ovestad I.T., Gudlaugsson E., Skaland I., Malpica A., Munk A.C., Janssen E.A., Baak J.P. The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2–3. J. Clin. Pathol. 2011; 64(4): 303-7. doi: 10.1136/jcp.2010.083626.

30. Sodhani P., Gupta S., Gupta R., Mehrotra R. Bacterial vaginosis and cervical intraepithelial neoplasia: is there an association or is co-existence incidental? Asian Pac. J. Cancer Prev. 2017; 18(5): 1289-92. doi: 10.22034/APJCP.2017.18.5.1289.

31. Oh H.Y., Kim B.S., Seo S.S., Kong J.S., Lee J.K., Park S.Y. et al. The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea. Clin. Microbiol. Infect. 2015; 21(7): 674. e1-9. doi: 10.1016/j.cmi.2015.02.026.

32. Palma E., Recine N., Domenici L., Giorgini M., Pierangeli A., Panici P.B. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection. BMC Infect. Dis. 2018; 18: 13. doi: 10.1186/s12879-017-2938-z.

33. Роговская С.И., Теребнева Л.И. Клинические аспекты плоскоклеточных интраэпителиальных поражений низкой степени. Акушерство и гинекология. 2013; 2: 136-43. [Rogovskaya S.I., Terebneva L.I. Clinical aspects of squamous intraepithelial lesions of low degree. Obstetrics and Gynecology / Akusherstvo i ginekologiya. 2013; 2: 136-43 (in Russian)].

34. Савельева Г.М., Сухих Г.Т., Серов В.Н., Радзинский В.Е., ред. Акушерство. Национальное руководство. 2-е изд. М.: ГЭОТАР-Медиа; 2015. 1080с. [Obstetrics. National leadership. Ed.: G.M. Savelieva, G.T. Sukhikh, V.N. Serov, V.E. Radzinsky. 2-nd ed. Moscow: GEOTAR-Media; 2015. 1080 p. (in Russian)].

35. Бебнева Т.Н., Дикке Г.Б. Коррекция рецидивирующих нарушений биоценоза влагалища у беременных, инфицированных вирусом папилломы человека. Акушерство и гинекология: новости, мнения, обучение. 2018; 3: 38-46. [Bebneva TN, Dikke G.B. Correction of recurrent vaginal biocenosis disorders in pregnant women infected with human papillomavirus. Obstetrics and gynecology: news, opinions, training / Akusherstvo i ginekologiya: novosti, mneniya, obucheniye. 2018; 6 (3): 38-46 (in Russian)].

36. World Health Organization. WHO guidelines for the treatment of Chlamydia trachomatis. Geneva: World Health Organization; 2016. 47р.

37. Bradshaw C.S., Sobel J.D. Current treatment of bacterial vaginosis-limitations and need for innovation. J. Infect. Dis. 2016; 214(Suppl. 1): S14-20. doi: 10.1093/infdis/jiw159.

38. Sherrard1 J., Donders G., White D., Jensen J.S. European (IUSTI/WHO) guideline on the management of vaginal discharge. 2011. 23р. Available at: http://www.iusti.org/

39. Бальмер Дж.А. и Группа мультицентрового исследования (Мультицентровое Европейское исследование) Макмирор комплекс в лечении вульвовагинитов, вызванных смешанной грибковой, бактериальной и трихомонадной инфекцией. Провизор. 2001; 19: 32-3. [Balmer J.A. and a multicenter study group. The combination of nifuratel and nystatin (Macmiore complex) in the treatment of vulvovaginitis caused by mixed fungal, bacterial and trichomonas infection. Medical and social problems of the family. 2012; 3-4 (17): el. version. URL: http://www.mif-ua.com/archive/article_print/34220. (in Russian)].

40. Захарова Т.В., Волков В.Г. Опыт лечения бактериального вагиноза, ассоцированного с кандидозным вульвовагинитом. Акушерство и гинекология. 2016; 11: 131-5. doi: 10.18565/aig.2016.11.131-5. [Zakharova TV, Volkov VG. Experience in the treatment of bacterial vaginosis, associated with candidal vulvovaginitis. Obstetrics and Gynecology / Akusherstvo i ginekologiya. 2016; 11: 131-5. DOI: 10.18565/aig.2016.11.131-5.(inRussian)].

41. Сергиенко Г.С., Тазина Т.В., Жучков М.В. Возможности вагинального крема, содержащего клиндамицин и бутоконазол, в уменьшении риска рецидива урогенитального кандидоза у коморбидных пациенток с бактериальным вагинозом. Гинекология. 2018; 20(1): 68-70. [Sergienko GS, Tazina ТV, Zhuchkov MV. The possibilities of vaginal cream containing clindamycin and butoconazole in reducing the risk of recurrence of urogenital candidiasis in comorbid patients with bacterial vaginosis. Gynecology / Ginekologiya. 2018; 01: 68-70. (inRussian)].

42. Тихомиров А.Л., Сарсания С.И., Тускаев К.С. Актуальность применения повидон-йода в практике акушера-гинеколога. РМЖ. Мать и дитя. 2014; 22(1): 50-3. [Tikhomirov AL, Sarsania SI, Tuskayev KS. The relevance of the use of povidone-iodine in the practice of an obstetrician-gynecologist. RMJ. Mother and child. 2014; 1: 50-54. (in Russian)].

43. Додова Е.Г., Аполихина И.А., Горбунова Е.А., Бородина Е.А. Комплексное лечение воспалительных заболеваний нижних отделов генитального тракта у женщин. Акушерство и гинекология. 2015; 6: 129-35. [Dodova YeG, Apolikhina IA, Gorbunova YeA, Borodina YeA. Complex treatment of inflammatory diseases of the lower genital tract in women. Obstetrics and gynecology / Akusherstvo i ginekologiya. 2015; 6: 129-35. (in Russian)].

44. Mendling W., Weissenbacher E.R., Gerber S., Prasauskas V., Grob P. Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Arch. Gynecol. Obstet. 2016; 293(3): 469-84. doi: 10.1007/s00404-015-3914-8.

45. Verstraelen H., Verhelst R., Roelens K., Temmerman M. Antiseptics and disinfectants for the treatment of bacterial vaginosis: a systematic review. BMC Infect. Dis. 2012; 12: 148. doi: 10.1186/1471-2334-12-148.

46. Homayouni A., Bastani P., Ziyadi S., Mohammad-Alizadeh-Charandabi S., Ghalibaf M., Mortazavian A.M., Mehrabany E.V. Effects of probiotics on the recurrence of bacterial vaginosis: a review. J. Low. Genit. Tract Dis. 2014; 18(1): 79-86. doi: 10.1097/LGT.0b013e31829156ec.

Received 07.09.2018

Accepted 21.09.2018

About the Authors

Bebneva, Tamara N., Candidate of Medical Sciences, Associate Professor of the Department of Obstetrics, Gynecology and Reproductive Medicine, Faculty of Advanced Training for Medical Professionals of the Medical Institute of the Russian State University of People’s Friendship of the Ministry of Education and Science;
the doctor of the NMISE of the Ministry of Health of Russia.
117198, Moscow, ul. Miklukho-Maklaya, 21, building. 3. Phone: +7 916 518 19 64. E–mail: bebn@mail.ru. ORCID.org 0000–0001–9524–8962.
Dikke, Galina B., doctor of medical sciences, associate professor, Professor of the Department of Obstetrics and Gynecology with a course of reproductive medicine,
Private Educational Institution «Academy of Medical Education named F.I. Inozemtsev», St. Petersburg.
190013, St. Petersburg, Moscow Ave, 22, letter M, tel.: 8 (812) 334–76–50. E–mail: galadikke@yandex.ru. ORCID.org 0000–0001–9524–8962.

For citations: Bebneva T.N., Dikke G.B. Low–grade intraepithelial cervical lesions in pregnant women with HPV and vaginal biocenotic disorders. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2018; (11): 152-8. (in Russian)

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.